<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35196023</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>633</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS.</ArticleTitle><Pagination><StartPage>eabj0264</StartPage><MedlinePgn>eabj0264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.abj0264</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an estimated heritability between 40 and 50%. DNA methylation patterns can serve as proxies of (past) exposures and disease progression, as well as providing a potential mechanism that mediates genetic or environmental risk. Here, we present a blood-based epigenome-wide association study meta-analysis in 9706 samples passing stringent quality control (6763 patients, 2943 controls). We identified a total of 45 differentially methylated positions (DMPs) annotated to 42 genes, which are enriched for pathways and traits related to metabolism, cholesterol biosynthesis, and immunity. We then tested 39 DNA methylation-based proxies of putative ALS risk factors and found that high-density lipoprotein cholesterol, body mass index, white blood cell proportions, and alcohol intake were independently associated with ALS. Integration of these results with our latest genome-wide association study showed that cholesterol biosynthesis was potentially causally related to ALS. Last, DNA methylation at several DMPs and blood cell proportion estimates derived from DNA methylation data were associated with survival rate in patients, suggesting that they might represent indicators of underlying disease processes potentially amenable to therapeutic interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hop</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-9007-7436</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwamborn</LastName><ForeName>Ramona A J</ForeName><Initials>RAJ</Initials><Identifier Source="ORCID">0000-0003-3952-5042</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hannon</LastName><ForeName>Eilis</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6840-072X</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shireby</LastName><ForeName>Gemma L</ForeName><Initials>GL</Initials><Identifier Source="ORCID">0000-0002-8238-0080</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nabais</LastName><ForeName>Marta F</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0002-9545-5889</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0003-2222-4577</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rheenen</LastName><ForeName>Wouter</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5860-1533</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Vugt</LastName><ForeName>Joke J F A</ForeName><Initials>JJFA</Initials><Identifier Source="ORCID">0000-0002-4161-4004</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dekker</LastName><ForeName>Annelot M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westeneng</LastName><ForeName>Henk-Jan</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tazelaar</LastName><ForeName>Gijs H P</ForeName><Initials>GHP</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Eijk</LastName><ForeName>Kristel R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisse</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8880-9311</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven 3000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain and Disease Research, Leuven 3000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospitals Leuven, Department of Neurology, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baird</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Translational Biology, Biogen, Boston, MA 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol BS8 2BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Khleifat</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacoangeli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Biomedical Research Centre and Dementia Unit, South London and Maudsley NHS Foundation Trust and King's College London, London SE5 8AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5963-7426</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan 20149, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Universit&#xe0; degli Studi di Milano, Milan 20122, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratti</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4264-6614</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan 20149, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, Universit&#xe0; degli Studi di Milano, Milano 20145, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper-Knock</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0873-8689</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Karen E</ForeName><Initials>KE</Initials><Identifier Source="ORCID">0000-0003-0216-5717</Identifier><AffiliationInfo><Affiliation>School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-8925-2567</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basak</LastName><ForeName>A Nazli</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0001-6977-2517</Identifier><AffiliationInfo><Affiliation>Koc University, School of Medicine, Translational Medicine Research Center, NDAL, Istanbul, 34450, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9579-5341</Identifier><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, ALS Centre, University of Torino, Turin 10126, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza, SC Neurologia 1U, Turin 10126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5122-7243</Identifier><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, ALS Centre, University of Torino, Turin 10126, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza, SC Neurologia 1U, Turin 10126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7377-7222</Identifier><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, ALS Centre, University of Torino, Turin 10126, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza, SC Neurologia 1U, Turin 10126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5876-4079</Identifier><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, ALS Centre, University of Torino, Turin 10126, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza, SC Neurologia 1U, Turin 10126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, ALS Centre, University of Torino, Turin 10126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6714-6897</Identifier><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, ALS Centre, University of Torino, Turin 10126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotkine</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2541-6232</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerner</LastName><ForeName>Yossef</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabari</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vourc'h</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7960-8139</Identifier><AffiliationInfo><Affiliation>Service de Biochimie et Biologie mol&#xe9;culaire, CHU de Tours, Tours 37044, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR 1253, Universit&#xe9; de Tours, Inserm, Tours 37044, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UMR 1253, Universit&#xe9; de Tours, Inserm, Tours 37044, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence sur la SLA, CHU de Tours, Tours 37044, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence sur la SLA, CHRU de Limoges, Limoges 87042, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR 1094, Universit&#xe9; de Limoges, Inserm, Limoges 87025, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora Pardina</LastName><ForeName>Jesus S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-6633-5354</Identifier><AffiliationInfo><Affiliation>ALS Unit, Hospital San Rafael, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salas</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8323-6371</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hospital La Paz-Carlos III, Madrid 28046, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dion</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Montr&#xe9;al Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Jay P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-8183-2524</Identifier><AffiliationInfo><Affiliation>Montr&#xe9;al Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, QC H3A 0C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-2820-8183</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathers</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Calvary Health Care Bethlehem, Parkdale, VIC 3195, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCombe</LastName><ForeName>Pamela A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, University of Queensland, Brisbane, QLD 4019, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Needham</LastName><ForeName>Merrilee</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Notre Dame University, Fremantle, WA 6160, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Garth</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ANZAC Research Institute, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Dominic B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0003-0912-2146</Identifier><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie University, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamphlett</LastName><ForeName>Roger</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3326-7273</Identifier><AffiliationInfo><Affiliation>Discipline of Pathology and Department of Neuropathology, Brain and Mind Centre, University of Sydney, Sydney, NSW 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mather</LastName><ForeName>Karen A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0003-4143-8941</Identifier><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia Institute, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachdev</LastName><ForeName>Perminder S</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0002-9595-3220</Identifier><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuropsychiatric Institute, Prince of Wales Hospital, UNSW, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furlong</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie University, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garton</LastName><ForeName>Fleur C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henders</LastName><ForeName>Anjali K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0003-3672-1451</Identifier><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Shyuan T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, University of Queensland, Brisbane, QLD 4019, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, QLD 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, University of Queensland, Brisbane, QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyn</LastName><ForeName>Frederik J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, University of Queensland, Brisbane, QLD 4019, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Sciences, University of Queensland, Brisbane, QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Leanne</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4310-7572</Identifier><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Kelly L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0001-6319-9473</Identifier><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie University, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>BIOS Consortium</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Brain MEND Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>Miguel Mitne</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo 05508-070, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cauchi</LastName><ForeName>Ruben J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-6150-1608</Identifier><AffiliationInfo><Affiliation>Center for Molecular Medicine and Biobanking and Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, 2023 Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie University, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-9054-026X</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drory</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv 64239, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povedano</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona 08907, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Mamede</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7556-0158</Identifier><AffiliationInfo><Affiliation>Instituto de Fisiologia, Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Susana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0727-5897</Identifier><AffiliationInfo><Affiliation>Instituto de Fisiologia, Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5538-9274</Identifier><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouleau</LastName><ForeName>Guy A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Montr&#xe9;al Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7698-3854</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan 20149, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Universit&#xe0; degli Studi di Milano, Milan 20122, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landers</LastName><ForeName>John E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-8084-5043</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0003-0251-0146</Identifier><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-0094-5429</Identifier><AffiliationInfo><Affiliation>Department of Clinical Science, Ume&#xe5; University, Ume&#xe5; SE-901 85, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McRae</LastName><ForeName>Allan F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-5286-5485</Identifier><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Es</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasterkamp</LastName><ForeName>R Jeroen</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wray</LastName><ForeName>Naomi R</ForeName><Initials>NR</Initials><Identifier Source="ORCID">0000-0001-7421-3357</Identifier><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, University of Queensland, Brisbane, QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLaughlin</LastName><ForeName>Russell L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0003-3915-2135</Identifier><AffiliationInfo><Affiliation>Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardiman</LastName><ForeName>Orla</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-2610-1291</Identifier><AffiliationInfo><Affiliation>Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02 PN40, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenna</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5625-1189</Identifier><AffiliationInfo><Affiliation>Translational Biology, Biogen, Boston, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Runz</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2133-7345</Identifier><AffiliationInfo><Affiliation>Translational Biology, Biogen, Boston, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4924-7712</Identifier><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College Hospital, Denmark Hill, London SE5 9RS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-6559-3965</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4010-2357</Identifier><AffiliationInfo><Affiliation>KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven 3000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain and Disease Research, Leuven 3000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospitals Leuven, Department of Neurology, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mill</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1115-3224</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5572-9657</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht 3584 CX, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R56 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>SHAW/APR18/864-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1100695</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ALCHALABI-DOBSON/APR14/829-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0500289</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0300329</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SHAW/NOV14/985-797</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0900688</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FRN 159279</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>MR/L021803/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0900635</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_17115</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0600974</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests</b>: J.H.V. has sponsored research agreements with Biogen. L.H.v.d.B. receives personal fees from Cytokinetics, outside the submitted work. A.A.-C. has served on scientific advisory boards for Mitsubishi Tanabe Pharma, OrionPharma, Biogen Idec, Lilly, GSK, Apellis, Amylyx, and Wave Therapeutics. A.C. serves on scientific advisory boards for Mitsubishi Tanabe, Roche, Biogen, Denali, and Cytokinetics. P.V.D. reports grants from CSL Behring (paid to institution and participated in advisory board meetings of Biogen, Alexion Pharmaceuticals, Ferrer, QurAlis, argenx, UCB, and Augustine Therapeutics (paid to institution). P.M.A. works as a consultant to Biogen, Roche, Avrion, Regeneron, and Orphazyme; as a clinical trial site investigator for Biogen, Alexion, Sanofi, AL-S Pharma, Amylyx, and Orphazyme; as, since 1993, Director of the ALS genetic laboratory at Ume&#xe5; University Hospital that performs genetic testing for SOD1 mutation; and as a member of the ClinGen ALS Gene Curation Expert panel.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Heijmans</LastName><ForeName>Bastiaan T</ForeName><Initials>BT</Initials></Investigator><Investigator ValidYN="Y"><LastName>T Hoen</LastName><ForeName>Peter A C</ForeName><Initials>PAC</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Meurs</LastName><ForeName>Joyce</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jansen</LastName><ForeName>Rick</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franke</LastName><ForeName>Lude</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boomsma</LastName><ForeName>Dorret I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pool</LastName><ForeName>Rene</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dongen</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hottenga</LastName><ForeName>Joukje J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Greevenbroek</LastName><ForeName>Marleen M J</ForeName><Initials>MMJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stehouwer</LastName><ForeName>Coen D A</ForeName><Initials>CDA</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Kallen</LastName><ForeName>Carla J H</ForeName><Initials>CJH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schalkwijk</LastName><ForeName>Casper G</ForeName><Initials>CG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijmenga</LastName><ForeName>Cisca</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franke</LastName><ForeName>Lude</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhernakova</LastName><ForeName>Sasha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tigchelaar</LastName><ForeName>Ettje F</ForeName><Initials>EF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slagboom</LastName><ForeName>P Eline</ForeName><Initials>PE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beekman</LastName><ForeName>Marian</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deelen</LastName><ForeName>Joris</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Heemst</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5572-9657</Identifier></Investigator><Investigator ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-6559-3965</Identifier></Investigator><Investigator ValidYN="Y"><LastName>van Duijn</LastName><ForeName>Cornelia M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hofman</LastName><ForeName>Bert A</ForeName><Initials>BA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Isaacs</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uitterlinden</LastName><ForeName>Andre G</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Meurs</LastName><ForeName>Joyce</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jhamai</LastName><ForeName>P Mila</ForeName><Initials>PM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verbiest</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suchiman</LastName><ForeName>H Eka D</ForeName><Initials>HED</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verkerk</LastName><ForeName>Marijn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Breggen</LastName><ForeName>Ruud</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Rooij</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lakenberg</LastName><ForeName>Nico</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mei</LastName><ForeName>Hailiang</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Iterson</LastName><ForeName>Maarten</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Galen</LastName><ForeName>Michiel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bot</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhernakova</LastName><ForeName>Dasha V</ForeName><Initials>DV</Initials></Investigator><Investigator ValidYN="Y"><LastName>van 't Hof</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deelen</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nooren</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heijmans</LastName><ForeName>Bastiaan T</ForeName><Initials>BT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moed</LastName><ForeName>Matthijs</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8880-9311</Identifier></Investigator><Investigator ValidYN="Y"><LastName>Franke</LastName><ForeName>Lude</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vermaat</LastName><ForeName>Martijn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhernakova</LastName><ForeName>Dasha V</ForeName><Initials>DV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luijk</LastName><ForeName>Rene</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jan Bonder</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Iterson</LastName><ForeName>Maarten</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deelen</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Freerk</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Galen</LastName><ForeName>Michiel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arindrarto</LastName><ForeName>Wibowo</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kielbasa</LastName><ForeName>Szymon M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swertz</LastName><ForeName>Morris A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Zwet</LastName><ForeName>Erik W</ForeName><Initials>EW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4924-7712</Identifier></Investigator><Investigator ValidYN="Y"><LastName>Wray</LastName><ForeName>Naomi R</ForeName><Initials>NR</Initials><Identifier Source="ORCID">0000-0001-7421-3357</Identifier></Investigator><Investigator ValidYN="Y"><LastName>Bensimon</LastName><ForeName>Gilbert</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hardiman</LastName><ForeName>Orla</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-2610-1291</Identifier></Investigator><Investigator ValidYN="Y"><LastName>Chio</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9579-5341</Identifier></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>George Davey</ForeName><Initials>GD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mill</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1115-3224</Identifier></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35196023</ArticleId><ArticleId IdType="mid">NIHMS1869835</ArticleId><ArticleId IdType="pmc">PMC10040186</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abj0264</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH, Amyotrophic lateral sclerosis. Lancet 390, 2084&#x2013;2098 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O, Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 76, 1367&#x2013;1374 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 9, 617&#x2013;628 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue A, Jiang L, Zhu Z, Wray NR, Visscher PM, Zeng J, Yang J, Genome-wide analyses of behavioural traits are subject to bias by misreports and longitudinal changes. Nat. Commun. 12, 20211 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804181</ArticleId><ArticleId IdType="pubmed">33436567</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C, An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 22, 217&#x2013;228 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12792141</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Al Khleifat A, Al-Chalabi A, What causes amyotrophic lateral sclerosis? F1000Res. 6, 371 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373425</ArticleId><ArticleId IdType="pubmed">28408982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PA, Takai D, The role of DNA methylation in mammalian epigenetics. Science 293, 1068&#x2013;1070 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11498573</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;beler D, Function and information content of DNA methylation. Nature 517, 321&#x2013;326 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25592537</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith ZD, Meissner A, DNA methylation: Roles in mammalian development. Nat. Rev. Genet. 14, 204&#x2013;220 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23400093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dor Y, Cedar H, Principles of DNA methylation and their implications for biology and medicine. Lancet 392, 777&#x2013;786 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30100054</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabais MF, Laws SM, Lin T, Vallerga CL, Armstrong NJ, Blair IP, Kwok JB, Mather KA, Mellick GD, Sachdev PS, Wallace L, Henders AK, Zwamborn RAJ, Hop PJ, Lunnon K, Pishva E, Roubroeks JAY, Soininen H, Tsolaki M, Mecocci P, Lovestone S, K&#x142;oszewska I, Vellas B, Furlong S, Garton FC, Henderson RD, Mathers S, McCombe PA, Needham M, Ngo ST, Nicholson G, Pamphlett R, Rowe DB, Steyn FJ, Williams KL, Anderson TJ, Bentley SR, Dalrymple-Alford J, Fowder J, Gratten J, Halliday G, Hickie IB, Kennedy M, Lewis SJG, Montgomery GW, Pearson J, Pitcher TL, Silburn P, Zhang F, Visscher PM, Yang J, Stevenson AJ, Hillary RF, Marioni RE, Harris SE, Deary IJ, Jones AR, Shatunov A, Iacoangeli A, van Rheenen W, van den Berg LH, Shaw PJ, Shaw CE, Morrison KE, Al-Chalabi A, Veldink JH, Hannon E, Mill J, Wray NR, McRae AF, Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biol. 22, 90 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8004462</ArticleId><ArticleId IdType="pubmed">33771206</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollepalli S, Korhonen T, Kaprio J, Anders S, Ollikainen M, EpiSmokEr: A robust classifier to determine smoking status from DNA methylation data. Epigenomics 11, 1469&#x2013;1486 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31466478</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Marioni RE, Hedman &#xc5;K, Pfeiffer L, Tsai P-C, Reynolds LM, Just AC, Duan Q, Boer CG, Tanaka T, Elks CE, Aslibekyan S, Brody JA, K&#xfc;hnel B, Herder C, Almli LM, Zhi D, Wang Y, Huan T, Yao C, Mendelson MM, Joehanes R, Liang L, Love S-A, Guan W, Shah S, A. F M.c. Rae A. Kretschmer H. Prokisch K. Strauch A. Peters PM. Visscher NR. Wray X. Guo KL. Wiggins AK. Smith EB. Binder KJ. Ressler MR. Irvin DM. Absher D. Hernandez L. Ferrucci S. Bandinelli K. Lohman J. Ding L. Trevisi S. Gustafsson JH. Sandling L. Stolk AG. Uitterlinden I. Yet JE. Castillo-Fernandez TD. Spector JD. Schwartz P Vokonas L. Lind Y. Li M. Fornage DK. Arnett NJ Wareham N. Sotoodehnia KK. Ong JB. van Meurs J, Conneely KN, Baccarelli AA, Deary IJ, Bell JT, North KE, Liu Y, Waldenberger M, London SJ, Ingelsson E, Levy D, A DNA methylation biomarker of alcohol consumption. Mol. Psychiatry 23, 422&#x2013;433 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575985</ArticleId><ArticleId IdType="pubmed">27843151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton OKL, Zhang Q, McRae AF, Walker RM, Morris SW, Redmond P, Campbell A, Murray AD, Porteous DJ, Evans KL, McIntosh AM, Deary IJ, Marioni RE, An epigenetic score for BMI based on DNA methylation correlates with poor physical health and major disease in the Lothian Birth Cohort. Int. J. Obes. 43, 1795&#x2013;1802 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6760607</ArticleId><ArticleId IdType="pubmed">30842548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Vallerga CL, Walker RM, Lin T, Henders AK, Montgomery GW, He J, Fan D, Fowdar J, Kennedy M, Pitcher T, Pearson J, Halliday G, Kwok JB, Hickie I, Lewis S, Anderson T, Silburn PA, Mellick GD, Harris SE, Redmond P, Murray AD, Porteous DJ, Haley CS, Evans KL, McIntosh AM, Yang J, Gratten J, Marioni RE, Wray NR, Deary IJ, McRae AF, Visscher PM, Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. Genome Med. 11, 54 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6708158</ArticleId><ArticleId IdType="pubmed">31443728</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney DL, Hillary RF, Stevenson AJ, Ritchie SJ, Walker RM, Zhang Q, Morris SW, Bermingham ML, Campbell A, Murray AD, Whalley HC, Gale CR, Porteous DJ, Haley CS, McRae AF, Wray NR, Visscher PM, McIntosh AM, Evans KL, Deary IJ, Marioni RE, Epigenetic prediction of complex traits and death. Genome Biol. 19, 136 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158884</ArticleId><ArticleId IdType="pubmed">30257690</ArticleId></ArticleIdList></Reference><Reference><Citation>Ligthart S, Marzi C, Aslibekyan S, Mendelson MM, Conneely KN, Tanaka T, Colicino E, Waite LL, Joehanes R, Guan W, Brody JA, Elks C, Marioni R, Jhun MA, Agha G, Bressler J, Ward-Caviness CK, Chen BH, Huan T, Bakulski K, Salfati EL; WHI-EMPC Investigators G Fiorito; CHARGE epigenetics of Coronary Heart Disease S. Wahl K Schramm J Sha DG Hernandez AC Just JA. Smith N. Sotoodehnia LC Pilling JS Pankow PS Tsao C Liu W. Zhao S. Guarrera VJ. Michopoulos AK. Smith MJ. Peters D. Melzer P. Vokonas M. Fornage H Prokisch JC. Bis AY. Chu C. Herder H. Grallert C. Yao S. Shah A.l. F. Mc Rae H. Lin S. Horvath D. Fallin A. Hofman NJ. Wareham KL. Wiggins AP. Feinberg JM. Starr PM. Visscher JM Murabito SLR. Kardia DM Absher EB. Binder AB. Singleton S. Bandinelli A. Peters M. Waldenberger G. Matullo JD. Schwartz EW. Demerath AG. Uitterlinden JBJ. van Meurs OH Franco Y-D. Chen I, Levy D, Turner ST, Deary IJ, Ressler KJ, Dupuis J, Ferrucci L, Ong KK, Assimes TL, Boerwinkle E, Koenig W, Arnett DK, Baccarelli AA, Benjamin EJ, Dehghan A, DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 17, 255 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5151130</ArticleId><ArticleId IdType="pubmed">27955697</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadd DA, Hillary RF, McCartney DL, Stevenson AJ, Nangle C, Flaig R, Harris SE, Walker RM, Shi L, Tucker-Drob EM, Deary IJ, Porteous DJ, Hayward C, Visscher PM, Cox SR, Evans KL, McIntosh AM, Marioni RE, DNA methylation proxies for 16 plasma proteins predict the incidence of 7 leading causes of morbidity. BioRxiv, 2020.12.01.404681 (2020).</Citation></Reference><Reference><Citation>Amador C, Zeng Y, Barber M, Walker RM, Campbell A, McIntosh AM, Evans KL, Porteous DJ, Hayward C, Wilson JF, Navarro P, Haley CS, Genome-wide methylation data improves dissection of the effect ofsmoking on body mass index. PLOS Genet. 17, e1009750 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428545</ArticleId><ArticleId IdType="pubmed">34499657</ArticleId></ArticleIdList></Reference><Reference><Citation>van Iterson M, van Zwet EW, Heijmans BT, Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution. Genome Biol. 18, 19 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5273857</ArticleId><ArticleId IdType="pubmed">28129774</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Chen W, Zhu Z, Zhang Q, Nabais MF, Qi T, Deary IJ, Wray NR, Visscher PM, McRae AF, Yang J, OSCA: A tool for omic-data-based complex trait analysis. Genome Biol. 20, 107 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537380</ArticleId><ArticleId IdType="pubmed">31138268</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzer G, meta: An R package for meta-analysis (2019).</Citation></Reference><Reference><Citation>Fortin J-P, Labbe A, Lemire M, Zanke BW, Hudson TJ, Fertig EJ, Greenwood CM, Hansen KD, Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 15, 503 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4283580</ArticleId><ArticleId IdType="pubmed">25599564</ArticleId></ArticleIdList></Reference><Reference><Citation>Pidsley R, Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC, A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 14, 293 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3769145</ArticleId><ArticleId IdType="pubmed">23631413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hop PJ, Zwamborn RAJ, Hannon EJ, Dekker AM, van Eijk KR, Walker EM, Iacoangeli A, Jones AR, Shatunov A, Khleifat AA, Opie-Martin S, Shaw CE, Morrison KE, Shaw PJ, McLaughlin RL, Hardiman O, Al-Chalabi A, van den Berg LH, Mill J, Veldink JH, Cross-reactive probes on Illumina DNA methylation arrays: Alarge study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies. NAR Genom. Bioinformatics 2, lqaa105 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745769</ArticleId><ArticleId IdType="pubmed">33554115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell G, Gorrie-Stone TJ, Bao Y, Kumari M, Schalkwyk LS, Mill J, Hannon E, Guidance for DNA methylation studies: Statistical insights from the Illumina EPIC array. BMC Genomics 20, 366 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6518823</ArticleId><ArticleId IdType="pubmed">31088362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hop PJ, Luijk R, Daxinger L, van Iterson M, Dekkers KF, Jansen R; BIOS Consortium JBJ van Meurs, P. A. C. &#x2018;t Hoen, M. A. Ikram, M. M. J. Greevenbroek, D. I. Boomsma, P. E. Slagboom, J. H. Veldink, E. W. van Zwet, B. T. Heijmans, Genome-wide identification of genes regulating DNA methylation using genetic anchors for causal inference. Genome Biol. 21, 220 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453518</ArticleId><ArticleId IdType="pubmed">32859263</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, van der Spek RAA, Bakker MK, van Vugt JJFA, Hop PJ, Zwamborn RAJ, de Klein N, Westra H-J, Bakker OB, Deelen P, Shireby G, Hannon E, Moisse M, Baird D, Restuadi R, Dolzhenko E, Dekker AM, Gawor K, Westeneng H-J, Tazelaar GHP, van Eijk KR, Kooyman M, Byrne RP, Doherty M, Heverin M, Al Khleifat A, Iacoangeli A, Shatunov A, Ticozzi N, Cooper-Knock J, Smith BN, Gromicho M, Chandran S, Pal S, Morrison KE, Shaw PJ, Hardy J, Orrell RW, Sendtner M, Meyer T, Ba&#x15f;ak N, van der Kooi AJ, Ratti A, Fogh I, Gellera C, Lauria G, Corti S, Cereda C, Sproviero D, D&#x2019;Alfonso S, Sorar&#xf9; G, Siciliano G, Filosto M, Padovani A, Chi&#xf2; A, Calvo A, Moglia C, Brunetti M, Canosa A, Grassano M, Beghi E, Pupillo E, Logroscino G, Nefussy B, Osmanovic A, Nordin A, Lerner Y, Zabari M, Gotkine M, Baloh RH, Bell S, Vourc&#x2019;h P, Corcia P, Couratier P, Millecamps S, Meininger V, Salachas F, J. S M.o. Pardina A. Assialioui R. Rojas-Garc&#xed;a PA. Dion JP. Ross AC. Ludolph JH. Weishaupt D. Brenner A. Freischmidt G. Bensimon A. Brice A. Durr CAM. Payan S. Saker-Delye NW. Wood S. Topp R. Rademakers L. Tittmann W. Lieb A. Franke S. Ripke A. Braun J. Kraft DC. Whiteman CM. Olsen AG. Uitterlinden A. Hofman M. Rietschel S. Cichon MM. N&#xf6;then P. Amouyel; SLALOM Consortium; PARALS Consortium; SLAGEN Consortium; SLAP Consortium BJ. Traynor AB Singleton M. Neto M.i., Cauchi RJ, Ophoff RA, Wiedau-Pazos M, Lomen-Hoerth C, van Deerlin VM, Grosskreutz J, Roediger A, Gaur N, J&#xf6;rk A, Barthel T, Theele E, Ilse B, Stubendorff B, Witte OW, Steinbach R, H&#xfc;bner CA, Graff C, Brylev L, Fominykh V, Demeshonok V, Ataulina A, Rogelj B, Koritnik B, Zidar J, Ravnik-Glava&#x10d; M, Glava&#x10d; D, Stevi&#x107; Z, Drory V, Povedano M, Blair IP, Kiernan MC, Benyamin B, Henderson RD, Furlong S, Mathers S, McCombe PA, Needham M, Ngo ST, Nicholson GA, Pamphlett R, Rowe DB, Steyn FJ, Williams KL, Mather KA, Sachdev PS, Henders AK, Wallace L, de Carvalho M, Pinto S, Petri S, Weber M, Rouleau GA, Silani V, Curtis CJ, Breen G, Glass JD, Brown RH, Landers JE, Shaw CE, Andersen PM, Groen EJN, van Es MA, Pasterkamp RJ, Fan D, Garton FC, McRae AF, Smith G. D.a, Gaunt TR, Eberle MA, Mill J, McLaughlin RL, Hardiman O, Kenna KP, Wray NR, Tsai E, Runz H, Franke L, Al-Chalabi A, Van Damme P, van den Berg LH, Veldink JH, Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 53, 1636&#x2013;1648 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipson B, Maksimovic J, Oshlack A, missMethyl: An R package for analyzing data from Illumina&#x2019;s HumanMethylation450 platform. Bioinformatics 32, 286&#x2013;288 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26424855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Kuan PF, methylGSA: A Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing. Bioinformatics 35, 1958&#x2013;1959 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30346483</ArticleId></ArticleIdList></Reference><Reference><Citation>Staley J, Battram T, Crawford G, Prince C, Babaei MS, Hemani G, Suderman M, Relton C, Gaunt T, EWAS Catalog: The MRC-IEU catalog of epigenome-wide association studies [accessed 6 June 2020 at http://ewascatalog.org/].</Citation></Reference><Reference><Citation>Liu D, Zhao L, Wang Z, Zhou X, Fan X, Li Y, Xu J, Hu S, Niu M, Song X, Li Y, Zuo L, Lei C, Zhang M, Tang G, Huang M, Zhang N, Duan L, Lv H, Zhang M, Li J, Xu L, Kong F, Feng R, Jiang Y, EWASdb: Epigenome-wide association study database. Nucleic Acids Res. 47, D989&#x2013;D993 (2019), [accessed 6 June 202 at https://ngdc.cncb.ac.cn/ewas/atlas].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323898</ArticleId><ArticleId IdType="pubmed">30321400</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E, Fast unfolding of communities in large networks. J. Stat. Mech. Theory Exp. 2008, P10008 (2008).</Citation></Reference><Reference><Citation>Yousefi PD, Richmond R, Langdon R, Ness A, Liu C, Levy D, Relton C, Suderman M, Zuccolo L, Validation and characterisation of a DNA methylation alcohol biomarker across the life course. Clin. Epigenetics 11, 163 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6880546</ArticleId><ArticleId IdType="pubmed">31775873</ArticleId></ArticleIdList></Reference><Reference><Citation>Teschendorff AE, Breeze CE, Zheng SC, Beck S, A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinformatics 18, 105 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5307731</ArticleId><ArticleId IdType="pubmed">28193155</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S, DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015143</ArticleId><ArticleId IdType="pubmed">24138928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan J-B, Gao Y, Deconde R, Chen M, Rajapakse I, Friend S, Ideker T, Zhang K, Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359&#x2013;367 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780611</ArticleId><ArticleId IdType="pubmed">23177740</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, Martin S, Logroscino G, Rooney J, The changing picture of amyotrophic lateral sclerosis: Lessons from European registers. J. Neurol. Neurosurg. Psychiatry 88, 557&#x2013;563 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28285264</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey TJ, Kirk SE, Steyn FJ, Ngo ST, The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Semin. Cell Dev. Biol. 112, 69&#x2013;81 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32962914</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng B, Yang Q, Joshi RB, Liu Y, Akbar M, Song B-J, Zhou S, Wang X, Role of alcohol drinking in Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and amyotrophic lateral sclerosis. Int. J. Mol. Sci. 21, 2316 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177420</ArticleId><ArticleId IdType="pubmed">32230811</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallerga CL, Zhang F, Fowdar J, McRae AF, Qi T, Nabais MF, Zhang Q, Kassam I, Henders AK, Wallace L, Montgomery G, Chuang Y-H, Horvath S, Ritz B, Halliday G, Hickie I, Kwok JB, Pearson J, Pitcher T, Kennedy M, Bentley SR, Silburn PA, Yang J, Wray NR, Lewis SJG, Anderson T, Dalrymple-Alford J, Mellick GD, Visscher PM, Gratten J, Analysis of DNA methylation associates the cystine&#x2013;glutamate antiporter SLC7A11 with risk of Parkinson&#x2019;s disease. Nat. Commun. 11, 1238 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060318</ArticleId><ArticleId IdType="pubmed">32144264</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-J, van Veenhuijzen K, van der Spek RA, Peters S, Visser AE, van Rheenen W, Veldink JH, van den Berg LH, Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: A longitudinal, population-based, case-control study. Lancet Neurol. 20, 373&#x2013;384 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33894192</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P, Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 10, 75&#x2013;82 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Tall AR, Yvan-Charvet L, Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104&#x2013;116 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4669071</ArticleId><ArticleId IdType="pubmed">25614320</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape JA, Grose JH, The effects of diet and sex in amyotrophic lateral sclerosis. Rev. Neurol. (Paris) 176, 301&#x2013;315 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8915943</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Ho WY, Chang J-C, Ling S-C, Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: Cause, consequence, or epiphenomenon?FEBS J. in press; (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34469619</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt F, Hussain G, Dupuis L, Loeffler J-P, Henriques A , A plural role for lipids in motor neuron diseases: Energy, signaling and structure. Front. Cell. Neurosci. 8, 25 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929843</ArticleId><ArticleId IdType="pubmed">24600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ, Autophagy regulates lipid metabolism. Nature 458, 1131&#x2013;1135 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676208</ArticleId><ArticleId IdType="pubmed">19339967</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbero-Camps E, Roca-Agujetas V, Bartolessis I, de Dios C, Fern&#xe1;ndez-Checa JC, Mar&#xed; M, Morales A, Hartmann T, Colell A, Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion. Autophagy 14, 1129&#x2013;1154 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103708</ArticleId><ArticleId IdType="pubmed">29862881</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land L-C, Markovinovic A, Jakovac H, De Marchi F, Bilic E, Mazzini L, Kriz J, Munitic I, Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2, fcaa124 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Lee JD, Woodruff TM, Henderson RD , The peripheral immune system and amyotrophic lateral sclerosis. Front. Neurol. 11, 279 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, McKeever PM, Xi Z, Moreno D, Sato C, Bergsma T, McGoldrick P, Keith J, Robertson J, Zinman L, Rogaeva E, DNA methylation age acceleration is associated with ALS age of onset and survival. Acta Neuropathol. 139, 943&#x2013;946 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181538</ArticleId><ArticleId IdType="pubmed">32146547</ArticleId></ArticleIdList></Reference><Reference><Citation>El Khoury LY, Gorrie-Stone T, Smart M, Hughes A, Bao Y, Andrayas A, Burrage J, Hannon E, Kumari M, Mill J, Schalkwyk LC, Systematic underestimation of the epigenetic clock and age acceleration in older subjects. Genome Biol. 20, 283 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6915902</ArticleId><ArticleId IdType="pubmed">31847916</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ J, Liu EY, Wu K, Neal D, Suh ER, Irwin DJ, M.c CT. Millan MB. Harms NJ. Cairns EM. Wood SX. Xie L. Elman LM. Cluskey M. Grossman VM. Van Deerlin EB. Lee, Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 129, 39&#x2013;52 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282973</ArticleId><ArticleId IdType="pubmed">25388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun PR, Han S, Hing B, Nagahama Y, Gaul LN, Heinzman JT, Grossbach AJ, Close L, Dlouhy BJ, Howard III MA, Kawasaki H, Potash JB, Shinozaki G, Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals. Transl. Psychiatry 9, 47 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6355837</ArticleId><ArticleId IdType="pubmed">30705257</ArticleId></ArticleIdList></Reference><Reference><Citation>Farr&#xe9; P, Jones MJ, Meaney MJ, Emberly E, Turecki G, Kobor MS, Concordant and discordant DNA methylation signatures of aging in human blood and brain. Epigenetics Chromatin 8, 19 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430927</ArticleId><ArticleId IdType="pubmed">25977707</ArticleId></ArticleIdList></Reference><Reference><Citation>Lappalainen T, Greally JM, Associating cellular epigenetic models with human phenotypes. Nat. Rev. Genet. 18, 441&#x2013;451 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28555657</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases, El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 293&#x2013;299 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabais MF, Lin T, Benyamin B, Williams KL, Garton FC, Vinkhuyzen AAE, Zhang F, Vallerga CL, Restuadi R, Freydenzon A, Zwamborn RAJ, Hop PJ, Robinson MR, Gratten J, Visscher PM, Hannon E, Mill J, Brown MA, Laing NG, Mather KA, Sachdev PS, Ngo ST, Steyn FJ, Wallace L, Henders AK, Needham M, Veldink JH, Mathers S, Nicholson G, Rowe DB, Henderson RD, McCombe PA, Pamphlett R, Yang J, Blair IP, McRae AF, Wray NR, Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis. Npj Genomic Med. 5, 10 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7046630</ArticleId><ArticleId IdType="pubmed">32140259</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA, Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363&#x2013;1369 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4016708</ArticleId><ArticleId IdType="pubmed">24478339</ArticleId></ArticleIdList></Reference><Reference><Citation>van Iterson M, Tobi EW, Slieker RC, den Hollander W, Luijk R, Slagboom PE, Heijmans BT, MethylAid: Visual and interactive quality control of large Illumina 450k datasets. Bioinformatics 30, 3435&#x2013;3437 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25147358</ArticleId></ArticleIdList></Reference><Reference><Citation>van Iterson M, Cats D, Hop P; BIOS Consortium BT Heijmans, omicsPrint: Detection of data linkage errors in multiple omics studies. Bioinformatics 34, 2142&#x2013;2143 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29420690</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehne B, Drong AW, Loh M, Zhang W, Scott WR, Tan S-T, Afzal U, Scott J, Jarvelin M-R, Elliott P, McCarthy MI, Kooner JS, Chambers JC, A coherent approach for analysis of the Illumina HumanMethylation450 BeadChip improves data quality and performance in epigenome-wide association studies. Genome Biol. 16, 37 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4365767</ArticleId><ArticleId IdType="pubmed">25853392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Laird PW, Shen H, Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389466</ArticleId><ArticleId IdType="pubmed">27924034</ArticleId></ArticleIdList></Reference><Reference><Citation>Luijk R, Goeman JJ, Slagboom EP, Heijmans BT, van Zwet EW, An alternative approach to multiple testing for methylation QTL mapping reduces the proportion of falsely identified CpGs. Bioinformatics 31, 340&#x2013;345 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25282645</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston P, Parmar MKB, Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat. Med. 21, 2175&#x2013;2197 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12210632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CG, Time-varying covariates and coefficients in Cox regression models. Ann. Transl. Med. 6, 121 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015946</ArticleId><ArticleId IdType="pubmed">29955581</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MHB, de Jong SW, van Doormaal PTC, Weinreich SS, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH, Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J. Neurol. Neurosurg. Psychiatry 82, 1165&#x2013;1170 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21622937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunca C, &#x15e;eker T, Ak&#xe7;imen F, Co&#x15f;kun C, Bayraktar E, Palvadeau R, Zor S, Ko&#xe7;o&#x11f;lu C, Kartal E, &#x15e;en NE, Hamzeiy H, Erimi&#x15f; A&#xd6;, Norman U, Karakahya O, Olgun G, Akg&#xfc;n T, Durmu&#x15f; H, &#x15e;ahin E, &#xc7;akar A, G&#xfc;rsoy EB, Y&#x131;ld&#x131;z GB, &#x130;&#x15f;ak B, Ulu&#xe7; K, Hana&#x11f;as&#x131; H, Bilgi&#xe7; B, Turgut N, Aysal F, Erta&#x15f; M, Boz C, Kotan D, &#x130;driso&#x11f;lu H, Soysal A, Adatepe NU, Akal&#x131;n MA, Ko&#xe7; F, Tan E, Oflazer P, Deymeer F, Ta&#x15f;tan &#xd6;, &#xc7;i&#xe7;ek AE, Kavak E, Parman Y, Ba&#x15f;ak AN, Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database. Hum. Mutat. 41, e7&#x2013;e45 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32579787</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray S, Race V, Crabb&#xe9; V, Herdewyn S, Matthijs G, Goris A, Dubois B, Thijs V, Robberecht W, Van Damme P, Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: A Belgian cohort study. Neurobiol. Aging 34, 2890.e7&#x2013;2890.e12 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23870417</ArticleId></ArticleIdList></Reference><Reference><Citation>Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ; International Multiple Sclerosis Genetics Consortium, M. van Es; Australia and New Zealand MS Genetics Consortium, P. M. Andersen, J. Melki, V. Meininger, O. Hardiman, J. E. Landers, R. H. Brown, A. Shatunov, N. Leigh, A. Al-Chalabi, C. E. Shaw, B. J. Traynor, A. Chio, G. Restagno, G. Mora, R. A. Ophoff, J. R. Oksenberg, P. VanDamme, A. Compston, W. Robberecht, B. Dubois, L. H. van den Berg, P. L. De Jager, J. H. Veldink, P. I. W. de Bakker, No evidence forshared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum. Mol. Genet. 23, 1916&#x2013;1922 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943520</ArticleId><ArticleId IdType="pubmed">24234648</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD, Prognosis and epidemiology of amyotrophic lateral sclerosis. Clin. Pract. 3, 313&#x2013;320 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Elamin M, Bede P, Hardiman O, Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 83, 365&#x2013;367 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22399794</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev PS, Lammel A, Trollor JN, Lee T, Wright MJ, Ames D, Wen W, Martin NG, Brodaty H, Schofield PR; OATS research team A comprehensive neuropsychiatric study of elderly twins: The Older Australian Twins Study. Twin Res. Hum. Genet. 12, 573&#x2013;582 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19943720</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>